These data are thus consistent with our results showing high expression of kallikrein 6 and kallikrein 10 in USPC, a variant of endometrial carcinoma characterised by an aggressive biologic behaviour and an inborn resistance to chemotherapy (Nicklin and Copeland, 1996). The gene discussed is KLK6; the disease is endometrial carcinoma.